Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
JACC Basic Transl Sci ; 9(1): 65-77, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38362347

ABSTRACT

Endovascular repair of aortic dissection still presents significant limitations. Preserving the mechanical and biological properties set by the aortic microstructure is critical to the success of implantable grafts. In this paper, we present the performance of an adhesive bioresorbable patch designed to cover the entry tear of aortic dissections. We demonstrate the power of using a biomimetic scaffold in a vascular environment.

2.
EuroIntervention ; 14(1): 121-128, 2018 05 20.
Article in English | MEDLINE | ID: mdl-29633939

ABSTRACT

AIMS: With increasing attention to renovascular causes and targets for hypertension there arises a critical need for more detailed knowledge of renal arterial anatomy. However, a standardised nomenclature is lacking. The present study sought to develop a standardised nomenclature for renal anatomy considering the complexity and variation of the renal arterial tree and to assess the applicability of the nomenclature. METHODS AND RESULTS: One thousand hypertensive patients underwent invasive selective renal artery angiography in nine centres. Further, renovasography was performed in 249 healthy swine as a surrogate for normotensive anatomy. Anatomical parameters were assessed by quantitative vascular analysis. Patients' mean blood pressure was 168/90±26/17 mmHg. The right main renal artery was longer than the left (41±15 mm vs. 35±13 mm, p<0.001), but the left had a greater diameter (5.4±1.2 vs. 5.2±1.2 mm, p<0.001). Accessory renal arteries and renal artery disease were documented in 22% and 9% of the patients, respectively. Other than exhibiting a longer left main renal artery in uncontrolled hypertensives (+2.7 mm, p=0.034) there was no anatomical difference between patients with controlled and uncontrolled hypertension. Main renal artery mean diameter was smaller in patients with impaired kidney function (GFR <90 ml/min, left -0.5 mm, right -0.4 mm, both p<0.001). CONCLUSIONS: Renal arterial anatomy differs between sides but shows no difference between patients with and without blood pressure control. Impaired GFR was associated with small main renal artery diameter.


Subject(s)
Blood Pressure/physiology , Hypertension/pathology , Kidney/blood supply , Renal Artery/anatomy & histology , Adult , Aged , Aged, 80 and over , Animals , Arterial Pressure/physiology , Blood Pressure Determination/methods , Female , Humans , Hypertension/physiopathology , Male , Middle Aged , Renal Artery/physiopathology , Swine
3.
Interv Cardiol Clin ; 5(3): 307-320, 2016 07.
Article in English | MEDLINE | ID: mdl-28582029

ABSTRACT

Endovascular drug delivery continues to revolutionize the treatment of atherosclerosis in coronary and peripheral vasculature. The key has been to identify biologic agents that can counter the hyperplastic tissue responses to device expansion/implantation and to develop effective local delivery strategies that can maintain efficacious drug levels across the artery wall over the course of device effects. This article reviews the evolution of endovascular drug delivery technology, explains the mechanisms they use for drug release, and provides a quantitative mechanistic framework for relating drug release mode to arterial drug distribution and effect.


Subject(s)
Coronary Restenosis/prevention & control , Drug Delivery Systems/methods , Drug-Eluting Stents , Drug Liberation , Humans , Stents
4.
Interv Cardiol Clin ; 5(3): 391-403, 2016 07.
Article in English | MEDLINE | ID: mdl-28582036

ABSTRACT

Contemporary endovascular stents are the product of an iterative design and development process that leverages evolving concepts in vascular biology and engineering. This article reviews how insights into vascular pathophysiology, materials science, and design mechanics drive stent design and explain modes of stent failure. Current knowledge of pathologic processes is providing a more complete picture of the factors mediating stent failure. Further evolution of endovascular stents includes bioresorbable platforms tailored to treat plaques acutely and to then disappear after lesion pacification. Ongoing refinement of stent technology will continue to require insights from pathology to understand adverse events, refine clinical protocols, and drive innovation.


Subject(s)
Coronary Restenosis/prevention & control , Endovascular Procedures , Prosthesis Design , Prosthesis Failure , Stents , Absorbable Implants , Drug-Eluting Stents , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...